melatonin has been researched along with Macular Edema in 2 studies
Macular Edema: Fluid accumulation in the outer layer of the MACULA LUTEA that results from intraocular or systemic insults. It may develop in a diffuse pattern where the macula appears thickened or it may acquire the characteristic petaloid appearance referred to as cystoid macular edema. Although macular edema may be associated with various underlying conditions, it is most commonly seen following intraocular surgery, venous occlusive disease, DIABETIC RETINOPATHY, and posterior segment inflammatory disease. (From Survey of Ophthalmology 2004; 49(5) 470-90)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy and safety of melatonin for the treatment of chronic central serous chorioretinopathy (CSCR)." | 9.20 | Therapeutic benefit of melatonin in refractory central serous chorioretinopathy. ( Gramajo, AL; Juárez, CP; Luna, JD; Marquez, GE; Rosenstein, RE; Torres, VE, 2015) |
| "Melatonin acts as an antioxidant and regulator of mitochondrial bioenergetics and has a protective effect against ocular diseases." | 5.62 | Melatonin prevents blood-retinal barrier breakdown and mitochondrial dysfunction in high glucose and hypoxia-induced in vitro diabetic macular edema model. ( Chasan, T; Doğanlar, O; Doğanlar, ZB; Güçlü, H; Kurtdere, K; Turgut, E, 2021) |
| "To evaluate the efficacy and safety of melatonin for the treatment of chronic central serous chorioretinopathy (CSCR)." | 5.20 | Therapeutic benefit of melatonin in refractory central serous chorioretinopathy. ( Gramajo, AL; Juárez, CP; Luna, JD; Marquez, GE; Rosenstein, RE; Torres, VE, 2015) |
| "Melatonin acts as an antioxidant and regulator of mitochondrial bioenergetics and has a protective effect against ocular diseases." | 1.62 | Melatonin prevents blood-retinal barrier breakdown and mitochondrial dysfunction in high glucose and hypoxia-induced in vitro diabetic macular edema model. ( Chasan, T; Doğanlar, O; Doğanlar, ZB; Güçlü, H; Kurtdere, K; Turgut, E, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doğanlar, ZB | 1 |
| Doğanlar, O | 1 |
| Kurtdere, K | 1 |
| Güçlü, H | 1 |
| Chasan, T | 1 |
| Turgut, E | 1 |
| Gramajo, AL | 1 |
| Marquez, GE | 1 |
| Torres, VE | 1 |
| Juárez, CP | 1 |
| Rosenstein, RE | 1 |
| Luna, JD | 1 |
1 trial available for melatonin and Macular Edema
| Article | Year |
|---|---|
Therapeutic benefit of melatonin in refractory central serous chorioretinopathy.
Topics: Administration, Oral; Adult; Aged; Antioxidants; Central Serous Chorioretinopathy; Female; Fluoresce | 2015 |
1 other study available for melatonin and Macular Edema
| Article | Year |
|---|---|
Melatonin prevents blood-retinal barrier breakdown and mitochondrial dysfunction in high glucose and hypoxia-induced in vitro diabetic macular edema model.
Topics: Apoptosis; Aryl Hydrocarbon Receptor Nuclear Translocator; Blood-Retinal Barrier; Cell Hypoxia; Cell | 2021 |